North American Dry Powdered Inhaler Market Top Leading Players with Strategies and Forecast 2025
North American dry powdered inhaler market was $7.2 billion in 2018 and is anticipated to grow at a substantial rate of 1.8% during the forecast period. The major factors that are contributing significantly in the market growth include rising air pollution, growing geriatric population, and high healthcare expenditure. The US and Canada are the major economies of North America. The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological advancement are the major factors augmenting the growth of dry powdered inhaler market in North America region. The increasing demand for inhaler due to increasing COPD and asthma patients in the US have endorsed the approval of cohesive reimbursement policies in the US, is further fueling the growth of the market. The US is the major market due to greater healthcare expenditure and higher prevalence rate of respiratory diseases.
To Request a Sample of our Report on North
American Dry Powdered Inhaler Market: https://www.omrglobal.com/request-sample/north-american-dry-powdered-inhaler-market
The North American dry powdered inhaler market is segmented
on the basis of type, application, and end-user. Based on the type, preventive,
reliever, and long acting bronchodilators inhaler are analyzed. Preventive dry
powdered inhaler segment led the global dry powdered inhaler market in 2018.
The preventive inhalers are most widely used in the treatment of asthma in
children and adults. These inhalers do not entail side effects for long-term
use, and exceptionally decreases the possibility of an asthma exacerbation. The
preventive inhalers further reduce the airways swelling and hence, are
recommended for regular use by the physician. Some of the preventive inhalers
available in market include Budesonide and Fluticasone. Moreover, on the basis
of application, the market has been classified into asthma and COPD diseases.
In addition, based on the end-user, homecare and hospitals and clinics have
been analyzed.
(Get 15% Discount on Buying this Report)
A
full Report of North American Dry Powdered Inhaler Market is Available @ https://www.omrglobal.com/industry-reports/north-american-dry-powdered-inhaler-market
North American Dry Powdered Inhaler Market Segmentation
By Type
·
Preventive Dry Powdered Inhaler
·
Reliever Dry Powdered Inhaler
·
Long Acting Bronchodilators Dry Powdered
Inhaler
By Application
·
Asthma
·
Chronic Obstructive Pulmonary Disease (COPD)
By End-User
·
Homecare
·
Hospitals and Clinics
Regional Analysis
·
US
·
Canada
Company Profiles
·
3M Co.
·
Acorda Therapeutics, Inc.
·
Adamis Pharmaceuticals Corp.
·
Adherium Ltd.
·
Aradigm Corp.
·
AstraZeneca PLC
·
Boehringer Ingelheim International GmbH
·
Drive Devilbiss Healthcare LLC
·
GlaxoSmithKline PLC
·
Koninklijke Philips N.V.
·
Manta Devices LL
·
Novartis AG
·
Omron Healthcare Inc.
·
ResMed Corp.
·
Pulmatrix Inc.
·
Savara, Inc.
·
Sunovion Pharmaceuticals
·
Teva Pharmaceuticals Industries Ltd.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment